Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial

Philippe Lechat, Jean‐Sébastien Hulot, Sylvie Escolano, Alain Mallet, Alain Leizorovicz · Circulation · 2001

Summary

B HR and HRC are significantly related to prognosis in heart failure and bisoprolol-induced benefit over placebo for survival was observed to a similar extent at any level of both BHR and HRC.

Type: article
Published: 2001-03-13
Cited by: 488
References: 13
Access: Open access
DOI: https://doi.org/10.1161/01.cir.103.10.1428
PubMed: https://pubmed.ncbi.nlm.nih.gov/11245648/
OpenAlex: https://openalex.org/W2056665255
Semantic Scholar: https://api.semanticscholar.org/CorpusID:20565140

Keywords

Medicine, Bisoprolol, Cardiology, Heart failure, Internal medicine

References

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)A. Hjalmarson, S. Goldstein, B. Fagerberg — 1999
Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction.M Nagatsu, Francis G. Spinale, Masaaki Koide — 2000
Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.Eric J. Eichhorn, John B. Bedotto, Craig R. Malloy — 1990
The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy.Donald V. Unverferth, Raymond D. Magorien, Richard P. Lewis — 1983
Sex Differences in the Prognosis of Congestive Heart Failure: Results From the Cardiac Insufficiency Bisoprolol Study (CIBIS II)Tabassome Simon, Murielle Mary‐Krause, Christian Funck‐Brentano — 2001
Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.Robert Soufer, Holley M. Dey, Chin K. Ng — 1995
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.Philippe Lechat, Milton Packer, Stephan Chalon — 1998
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.Lechat, P, Brunhuber, Kw, Hofmann, R — 1999
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.L. Wilkins — 1994
b-Adrenergic Receptor Blockade in Chronic Heart FailureM. Bristow — 2000

Cited by

Relationship of -Blocker Dose with Outcomes in Ambulatory Heart Failure Patients with Systolic Dysfunction: Results from the HF-ACTION TrialMona Fiuzat, Daniel Wojdyla, Dalane W. Kitzman — 2012
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.Bartolomé de las Casas, Vidal Abril Castelló — 2005
Heart Rate Control in an Unselected Consecutive Population of Outpatients With Stable Coronary Artery Disease: Analysis of the CARDIf Study CohortMartin Erlmann — 2010
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).Carla Nicole — 2011
Ablation of atrial arrhythmias in heart failure.David Mourão-Ferreira — 2015
Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies.Richard M. Anderson, R. Barry Nehring — 2015
The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.Stephen J. Greene, Muthiah Vaduganathan, Jane E. Wilcox — 2013
The effects of heart rate control in chronic heart failure with reduced ejection fractionLintang Nugrahani — 2018
Carvedilol: β-Blockade and BeyondAlice F. Stroe, Mihai Gheorghiade — 2004
Betabloqueantes en insuficiencia cardiaca: indicacionesLorenzo Silva Melchor, Javier Ortigosa Aso — 2003
It is all about heart rate. Or is it?Mohammad Sarraf, Gary S. Francis — 2012
How best to control the lack of oxygen in the ischemic cardiomyocyteFilippo Crea, Gaetano Antonio Lanza — 2009
Antiarrhythmic drug therapy in 2012: time to finally open our eyes!Michele Coceani — 2012
Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?Guo Yong-Fang, Yi An — 2011
La fréquence cardiaque au repos : Un indicateur pronostique modifiable du risque et des issues cardiovasculaires ?J. Malcolm O. Arnold, David Fitchett, Jonathan G. Howlett — 2008
Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).Hans R. Figulla, Maria Krzemińska‐Pakuła, Krzystof Wrabec — 2006
The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study PopulationR Ferrari, Roberto Ferrari, Ian Ford — 2007
VagusstimulationJuergen Kuschyk, Martin Borggrefe — 2011
beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.Daniela Dobre, Flora M. Haaijer‐Ruskamp, Adriaan A. Voors — 2007
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program.Davide Castagno, Hicham Skali, Madoka Takeuchi — 2012

Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial

Summary

Keywords

References

Cited by

Related papers